Literature DB >> 21911501

Toll-like receptor 3 (TLR3) signaling requires TLR4 Interactor with leucine-rich REPeats (TRIL).

Susan Carpenter1, Paulina Wochal, Aisling Dunne, Luke A J O'Neill.   

Abstract

Toll-like receptors (TLRs) are a family of proteins that act as the primary sensors of microbial products. Many TLRs require accessory molecules in order to recognize these microbial products and initiate signal transduction cascades. We have identified TRIL (TLR4 interactor with leucine-rich repeats) as a novel modulator of TLR4 signaling showing high expression in the brain. We now show that TRIL also plays a role in TLR3 signaling. TRIL is expressed intracellularly in the astrocytoma cell line U373 and in the monocytic cell line THP1. TRIL co-localizes with the endosomal compartment. These data are consistent with a role for TRIL in TLR3 signaling and endosomal TLR4 signaling. TRIL was induced by the TLR3 ligand poly(I:C). Overexpression of TRIL enhanced cytokine production and interferon-stimulated response element (ISRE) luciferase activity following poly(I:C) stimulation in U373. TRIL interacted with TLR3, and this interaction was enhanced following poly(I:C) stimulation. Transient knockdown of TRIL with siRNA or stable knockdown using shRNA in U373 cells inhibited TLR3 signaling, reducing ISRE luciferase, RANTES, and type I interferon production. Knockdown of TRIL did not affect TLR2 signaling. Most accessory molecules identified to date, such as CD14, gp96, PRAT4a, and Unc93B, all play roles in multiple TLR signaling pathways, and we now show that this is also the case for TRIL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911501      PMCID: PMC3207441          DOI: 10.1074/jbc.M111.255893

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  A protein associated with toll-like receptor 4 (PRAT4A) regulates cell surface expression of TLR4.

Authors:  Yasutaka Wakabayashi; Makiko Kobayashi; Sachiko Akashi-Takamura; Natsuko Tanimura; Kazunori Konno; Koichiro Takahashi; Takashi Ishii; Taketoshi Mizutani; Hideo Iba; Taku Kouro; Satoshi Takaki; Kiyoshi Takatsu; Yoshiya Oda; Yasushi Ishihama; Shin-ichiroh Saitoh; Kensuke Miyake
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 2.  The immune system evolved to discriminate infectious nonself from noninfectious self.

Authors:  C A Janeway
Journal:  Immunol Today       Date:  1992-01

3.  Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages.

Authors:  Yi Yang; Bei Liu; Jie Dai; Pramod K Srivastava; David J Zammit; Leo Lefrançois; Zihai Li
Journal:  Immunity       Date:  2007-02-01       Impact factor: 31.745

4.  The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9.

Authors:  Koichi Tabeta; Kasper Hoebe; Edith M Janssen; Xin Du; Philippe Georgel; Karine Crozat; Suzanne Mudd; Navjiwan Mann; Sosathya Sovath; Jason Goode; Louis Shamel; Anat A Herskovits; Daniel A Portnoy; Michael Cooke; Lisa M Tarantino; Tim Wiltshire; Benjamin E Steinberg; Sergio Grinstein; Bruce Beutler
Journal:  Nat Immunol       Date:  2006-01-15       Impact factor: 25.606

5.  Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105.

Authors:  Senad Divanovic; Aurelien Trompette; Sowsan F Atabani; Rajat Madan; Douglas T Golenbock; Alberto Visintin; Robert W Finberg; Alexander Tarakhovsky; Stefanie N Vogel; Yasmine Belkaid; Evelyn A Kurt-Jones; Christopher L Karp
Journal:  Nat Immunol       Date:  2005-04-24       Impact factor: 25.606

6.  CD14 is a coreceptor of Toll-like receptors 7 and 9.

Authors:  Christoph L Baumann; Irene M Aspalter; Omar Sharif; Andreas Pichlmair; Stephan Blüml; Florian Grebien; Manuela Bruckner; Pawel Pasierbek; Karin Aumayr; Melanie Planyavsky; Keiryn L Bennett; Jacques Colinge; Sylvia Knapp; Giulio Superti-Furga
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

7.  Essential role of MD-2 in LPS responsiveness and TLR4 distribution.

Authors:  Yoshinori Nagai; Sachiko Akashi; Masakazu Nagafuku; Masato Ogata; Yoichiro Iwakura; Shizuo Akira; Toshio Kitamura; Atsushi Kosugi; Masao Kimoto; Kensuke Miyake
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

8.  Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

Authors:  Hyun-Ku Lee; Stefan Dunzendorfer; Katrin Soldau; Peter S Tobias
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

9.  The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells.

Authors:  H Ogata; I Su; K Miyake; Y Nagai; S Akashi; I Mecklenbräuker; K Rajewsky; M Kimoto; A Tarakhovsky
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

10.  A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses.

Authors:  Koichiro Takahashi; Takuma Shibata; Sachiko Akashi-Takamura; Takashi Kiyokawa; Yasutaka Wakabayashi; Natsuko Tanimura; Toshihiko Kobayashi; Fumi Matsumoto; Ryutaro Fukui; Taku Kouro; Yoshinori Nagai; Kiyoshi Takatsu; Shin-ichiroh Saitoh; Kensuke Miyake
Journal:  J Exp Med       Date:  2007-11-06       Impact factor: 14.307

View more
  13 in total

Review 1.  Accessory molecules for Toll-like receptors and their function.

Authors:  Clarissa C Lee; Ana M Avalos; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2012-02-03       Impact factor: 53.106

2.  Tril targets Smad7 for degradation to allow hematopoietic specification in Xenopus embryos.

Authors:  Yangsook Song Green; Sunjong Kwon; Mizuho S Mimoto; Yuanyuan Xie; Jan L Christian
Journal:  Development       Date:  2016-09-15       Impact factor: 6.868

Review 3.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

4.  TRIL is involved in cytokine production in the brain following Escherichia coli infection.

Authors:  Paulina Wochal; Vijay A K Rathinam; Aisling Dunne; Thaddeus Carlson; Wen Kuang; Katherine J Seidl; J Perry Hall; Lih-Ling Lin; Mary Collins; Stefan A Schattgen; Christopher R MacKay; Caio T Fagundes; Susan Carpenter; Katherine A Fitzgerald; Luke A J O'Neill
Journal:  J Immunol       Date:  2014-07-11       Impact factor: 5.422

5.  Tril dampens Nodal signaling through Pellino2- and Traf6-mediated activation of Nedd4l.

Authors:  Hyung-Seok Kim; Yangsook Song Green; Yuanyuan Xie; Jan L Christian
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

6.  Toll-like receptor and accessory molecule mRNA expression in humans and mice as well as in murine autoimmunity, transient inflammation, and progressive fibrosis.

Authors:  Santhosh Kumar Vankyala Ramaiah; Roman Günthner; Maciej Lech; Hans-Joachim Anders
Journal:  Int J Mol Sci       Date:  2013-06-26       Impact factor: 5.923

7.  An ileal Crohn's disease gene signature based on whole human genome expression profiles of disease unaffected ileal mucosal biopsies.

Authors:  Tianyi Zhang; Bowen Song; Wei Zhu; Xiao Xu; Qing Qing Gong; Christopher Morando; Themistocles Dassopoulos; Rodney D Newberry; Steven R Hunt; Ellen Li
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

8.  An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti- and proinflammatory effector genes.

Authors:  Richard Leigh; Mahmoud M Mostafa; Elizabeth M King; Christopher F Rider; Suharsh Shah; Curtis Dumonceaux; Suzanne L Traves; Andrew McWhae; Tyler Kolisnik; Cora Kooi; Donna M Slater; Margaret M Kelly; Mark Bieda; Anna Miller-Larsson; Robert Newton
Journal:  Pharmacol Res Perspect       Date:  2016-07-12

9.  Fasciola hepatica Surface Tegument: Glycoproteins at the Interface of Parasite and Host.

Authors:  Alessandra Ravidà; Krystyna Cwiklinski; Allison M Aldridge; Paul Clarke; Roisin Thompson; Jared Q Gerlach; Michelle Kilcoyne; Cornelis H Hokke; John P Dalton; Sandra M O'Neill
Journal:  Mol Cell Proteomics       Date:  2016-07-27       Impact factor: 5.911

Review 10.  A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy.

Authors:  An Wouters; Evelien L J M Smits; Jorrit De Waele; Tias Verhezen; Sanne van der Heijden; Zwi N Berneman; Marc Peeters; Filip Lardon
Journal:  J Exp Clin Cancer Res       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.